company said it had taken the affected systems offline,
appointed external specialists to investigate the incident and
was in talks with relevant legal authorities, but did not
provide details on when the incident occurred or came to light.
The Leeds-based company's ability to manufacture at its U.S.
facility will be hit in the short term while the investigation
continues, it said, adding that the incident is not believed to
have affected its UK operations or financial systems.
Tissue Regenix, which was formed in 2006 when it was spun-out
from the University of Leeds, develops a special kind of tissue
that is not rejected by a patient's body and can be used to
repair diseased or worn out body parts.
The company said it was yet to quantify any potential financial
hit from the hack. Tissue Regenix set up its U.S. unit in late
Its shares, listed on London's junior AIM market, recovered some
losses to trade down 14.3% at 1.05 pence as of 1032 GMT.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by
Saumyadeb Chakrabarty, Bernard Orr)
[© 2020 Thomson Reuters. All rights
Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.